Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine.
Basnet S, Van der Heijden M, Quixabeira DCA, Jirovec E, Grönberg-Vähä-Koskela SAM, Clubb JHA, Kanerva A, Pakola S, Haybout L, Arias V, Hemminki O, Kudling T, Zafar S, Cervera-Carrascon V, Santos JM, Hemminki A.
Basnet S, et al.
Mol Ther. 2024 Sep 4;32(9):3114-3127. doi: 10.1016/j.ymthe.2024.06.029. Epub 2024 Jun 22.
Mol Ther. 2024.
PMID: 38910324
Free PMC article.